Therefore, these data show that indirubin may be a potential drug for combating obesity and obesity-related discords, in regard to its potential in inducing UCP1 expression and enhancing mitochondrial respiratory function in vitro. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.